The U.S. sternal closure systems market was estimated at USD 749.43 million in 2023 and it is expected to surpass around USD 1,178.4 million by 2033, poised to grow at a CAGR of 4.63% from 2024 to 2033.
U.S. Sternal Closure Systems Market Overview
U.S. Sternal Closure Systems Market Growth
In 2023, medial sternotomy held the largest market share at 52%. This procedure provides access to the heart, lungs, and surrounding structures, making it the preferred choice for heart valve replacement and coronary artery bypass surgeries. Medial sternotomy is renowned for its ability to minimize postoperative infections and complications, contributing to its growing demand in the global sternal closure systems market. The increasing elderly population, susceptible to chronic cardiovascular conditions, is expected to further drive the demand for medial sternotomy procedures.
On the other hand, the bilateral thoracosternotomy segment is poised for rapid expansion, projected to achieve the highest compound annual growth rate (CAGR) from 2024 to 2033. Also known as the clamshell incision, bilateral thoracosternotomy offers a viable option for lung transplantation, particularly in cases of end-stage pulmonary disorders such as Chronic Obstructive Pulmonary Disease (COPD), cystic fibrosis, and emphysema. With the growing prevalence of these conditions, the demand for lung transplantation procedures is anticipated to significantly boost market growth.
Material Type Insights
In 2023, stainless steel held the largest market share, accounting for approximately 28%. This dominance is attributed to the abundant availability of raw material suppliers and the economic feasibility and affordability associated with stainless steel. Known for its cost-effectiveness, durability, and ease of manufacturing, stainless steel remains a favored material type in the sternal closure systems market. Moreover, the market is witnessing an increase in new product launches by various companies, further driving the growth of stainless steel in this sector.
Meanwhile, the titanium segment is poised to experience the fastest compound annual growth rate (CAGR) from 2024 to 2033. This growth trajectory is fueled by several factors, including titanium’s corrosion resistance, its ability to effectively fuse with human bones, biocompatibility, and non-ferromagnetic properties. Notably, the non-ferromagnetic nature of titanium implants allows patients to safely undergo magnetic resonance imaging (MRI) scans. Additionally, the high efficacy, non-toxicity, and stability of titanium products contribute to their growing popularity within the sternal closure systems market.
Product Insights
Read More: https://www.heathcareinsights.com/u-s-teleradiology-market/
U.S. Sternal Closure Systems Market Key Companies
- DePuy Synthes
- Zimmer Biomet Holdings, LLC
- KLS Martin Group
- Stryker
- Johnson & Johnson,
- Orthofix Holdings Inc
- GE Healthcare
- A&E Medical Corporation
- Acute Innovations
- Abyrx, Inc
- Kinamed Incorporated
Recent Developments
- In February 2022, Evonik invested in US-based startup Circumfix for a novel sternal closure device to offer rapid patient recovery after open-chest surgery.
- In January 2023, Able Medical Devices introduced looped wire sutures for closing a patient’s chest after open-heart surgery. These sutures offer more robust sternal closure compared to traditional wire sutures and double the surface area of single wires.
U.S. Sternal Closure Systems Market Segmentations:
By Product
- Closure Devices
- Sternal Closure Wires
- Sternal Closure Plates and Screws
- Sternal Closure Clips
- Sternal Closure Cables
- Bone Cement
By Procedure
- Median Sternotomy
- Hemisternotomy
- Bilateral Thoracosternotomy
- Others
By Material
- Titanium
- Polyether Ether Ketone (PEEK)
- Stainless Steel
- Others
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41226
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308